--- a
+++ b/clusters/9knumclustersv2/clust_1154.txt
@@ -0,0 +1,50 @@
+Patients must not have baseline peripheral neuropathy that exceeds grade 
+=< grade  peripheral neuropathy; patients with grade  peripheral neuropathy with pain will be excluded
+Patients with a baseline peripheral neuropathy >= grade  will not be eligible
+Patients with preexisting grade II peripheral neuropathy
+Patients must not have peripheral neuropathy ? grade 
+Patients with greater than or equal to grade  peripheral neuropathy or active herpes infection
+Patients with > grade  peripheral neuropathy
+Patients with a peripheral neuropathy > grade 
+Patients with greater than or equal to grade  peripheral neuropathy at baseline
+Patients with a peripheral neuropathy > grade 
+Patients with peripheral neuropathy of > grade 
+Patients with preexisting peripheral neuropathy >= grade  are ineligible
+Patients with grade >=  peripheral neuropathy
+For the bortezomib arm of the study, patients with grade >=  peripheral neuropathy
+Patients with peripheral neuropathy greater than grade II
+Patients with grade  or greater peripheral neuropathy.
+Preexisting peripheral neuropathy is not allowed from any cause
+Patients with existing grade  or  peripheral neuropathy
+Patients with grade / peripheral neuropathy
+Patients who have baseline peripheral neuropathy >= grade  are not eligible
+Patients with >= grade  peripheral neuropathy
+Patients must not have peripheral neuropathy >= grade 
+Patients with peripheral neuropathy > grade  regardless of etiology
+Patients must not have peripheral neuropathy > grade 
+Patients must not have grade  or greater peripheral neuropathy
+Patients with grade  peripheral neuropathy or greater are excluded
+Patients with existing peripheral neuropathy grade > 
+Patients with grade II or greater peripheral neuropathy will be excluded from study
+COHORT II: Patients must not have >= grade  peripheral neuropathy
+Patients with greater than or equal to grade  peripheral neuropathy at baseline
+Peripheral neuropathy of grade >=. Patients with painful grade  neuropathy are also excluded
+Patients with peripheral neuropathy of grade >= ; patients with painful grade  neuropathy are also excluded
+Patients with peripheral neuropathy > 
+Patients with grade >=  peripheral neuropathy will not be permitted on study
+Patients with preexisting peripheral neuropathy grade >=  will not be eligible
+Patients with > grade  neuropathy according to the Modified (Balis) Pediatric Scale of Peripheral Neuropathies will be excluded except in cases in which neuropathy is secondary to prior surgery
+Subjects with preexisting Grade  or  neuropathy. Any peripheral neuropathy must recover to Grade less than or equal to  before enrollment
+Patients with peripheral neuropathy >= grade 
+Patients with greater than  screening peripheral neuropathy
+Patients who have grade >=  peripheral neuropathy
+Preexisting grade >=  peripheral neuropathy
+Patients with peripheral neuropathy >= grade  are not permitted unless discussed with the principal investigator and only in unique circumstances (i.e. unilateral neuropathy due to trauma)
+Part  only: Patients with >= grade  peripheral neuropathy.
+Patients with a >= grade  peripheral neuropathy
+Patients with peripheral neuropathy >= grade 
+Patients with peripheral neuropathy > grade  will be excluded from study participation
+Patients with symptomatic peripheral neuropathy> Grade .
+Patients must not have a history of peripheral neuropathy (regardless of cause)
+Patients with known, previously diagnosed peripheral neuropathy from causes other than chemotherapy
+Patients with known, previously diagnosed peripheral neuropathy from causes other than chemotherapy.